2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Conditions
Breast Neoplasms
1316
Neoplasms
1104
Carcinoma, Non-Small-Cell Lung
916
Prostatic Neoplasms
747
Colorectal Neoplasms
645
Lung Neoplasms
621
Neoplasm Metastasis
470
Multiple Myeloma
444
Leukemia, Myeloid, Acute
440
Pancreatic Neoplasms
392
Ovarian Neoplasms
388
Melanoma
346
Carcinoma, Hepatocellular
308
Brain Neoplasms
290
Squamous Cell Carcinoma of Head and Neck
285
Recurrence
285
Glioblastoma
260
Stomach Neoplasms
252
Head and Neck Neoplasms
250
Precursor Cell Lymphoblastic Leukemia-Lymphoma
238
Carcinoma, Renal Cell
237
Lymphoma
235
Triple Negative Breast Neoplasms
233
Endometrial Neoplasms
221
Uterine Cervical Neoplasms
217
Hematologic Neoplasms
216
Urinary Bladder Neoplasms
212
Lymphoma, Non-Hodgkin
203
Glioma
202
Sarcoma
200
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hemostatic Disorders
×
90 days
×
Clear all
NCT07075185
2026-04-24
inMMyCAR
Kelonia Therapeutics, Inc.
Phase 1
Recruiting
70 enrolled